Braftovi and Weakness - a phase IV clinical study of FDA data
Summary:
Weakness is reported as a side effect among people who take Braftovi (encorafenib), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Mektovi, and have Malignant melanoma.
The phase IV clinical study analyzes which people have Weakness when taking Braftovi. It is created by eHealthMe based on reports of 7,606 people who have side effects when taking Braftovi from the FDA, and is updated regularly.
What is Braftovi?
Braftovi has active ingredients of encorafenib. eHealthMe is studying from 7,609 Braftovi users. Check the latest studies of Braftovi.
What is Weakness?
Weakness is found to be associated with 3,639 drugs and 6,617 conditions by eHealthMe. Check the latest studies of Weakness.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
7,606 people reported to have side effects when taking Braftovi.
Among them, 232 people (3.05%) have Weakness.
Among these 232 people:
How long have people been on Braftovi when they have Weakness? *
What is the gender of people who have Weakness when taking Braftovi? *
What is the age of people who have Weakness when taking Braftovi? *
What are other drugs people take besides Braftovi? *
What are other side effects people have besides Weakness? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Braftovi and have Weakness?
- Check whether Weakness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Braftovi:
- Braftovi (7,609 reports)
Weakness treatments and more:
- Weakness (586,876 reports)
How severe was Weakness and when was it recovered:
Expand to all the drugs that have ingredients of encorafenib:
- Weakness and drugs with ingredients of encorafenib (224 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Braftovi:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Weakness:
- Weakness (3,639 drugs)
Browse all the conditions that are associated with Weakness:
- Weakness (6,617 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on encorafenib (the active ingredients of Braftovi) and Braftovi (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Lip And/Or Oral Cavity Cancer and drugs of ingredients of amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate - 4 seconds ago
- Drug interactions of Avelox and Pantoprazole - 7 seconds ago
- Hypertension Aggravated and drugs of ingredients of mifepristone - 8 seconds ago
- Alcoholism and drugs of ingredients of oxazepam - 8 seconds ago
- Sodium Chloride and Irbesartan drug interactions for men aged 60+ - 9 seconds ago
- Nabumetone and Aspartate Aminotransferase Increased for Women aged 60+ - 10 seconds ago
- Could Enbrel cause Pharyngolaryngeal Pain? - 15 seconds ago
- Hearing Impaired and drugs of ingredients of megestrol acetate - 17 seconds ago
- Pancytopenia and drugs of ingredients of gemfibrozil - 17 seconds ago
- Full Blood Count Decreased and drugs of ingredients of ipratropium bromide - 21 seconds ago